As consumers seek more enjoyable and convenient ways to take supplements, jelly is emerging as a fast-growing delivery format.
The supplement industry is entering an era in which how a product is consumed can be nearly as important as what is in it.
Consumers increasingly expect functional nutrition to be convenient, enjoyable and easy to incorporate into everyday routines. That shift is helping drive interest in alternative delivery formats, with jellies emerging as an increasingly important trend in the global supplement market.
For TCI Biotech, that trend is not simply about creating another consumer-friendly format. The company has established jellie manufacturing as a significant area of development, bringing together formulation science, manufacturing expertise and consumer insights to expand what can be achieved in a soft, flavourful and functional nutrition delivery system.
TCI’s growing focus on jellies comes as brands look for new ways to differentiate products while delivering meaningful levels of active ingredients.
“A jelly is much more than a different way to take a supplement. The real opportunity is to combine the science of the formulation with an experience that consumers genuinely enjoy,” says Dr. Rob Wildman, chief science officer at TCI Biotech.
“When we can deliver meaningful nutrient payloads in a format that is convenient, enjoyable and aligned with how consumers want to use supplements, we create a much stronger platform for innovation.”
Jellies are becoming a serious supplement trend
The growing interest in jellies reflects a broader change in consumer expectations around functional nutrition.
Consumers are increasingly comfortable with supplements that look and feel less pharmaceutical and more like products designed for everyday wellness. Texture, flavour, convenience and portability are becoming important considerations alongside ingredient selection and dosage.
Jellies fit naturally into that evolution. The format offers a soft, chewable experience while providing manufacturers with opportunities to develop products around specific nutritional and functional objectives.
For TCI Biotech, the opportunity is particularly compelling because of the company’s ability to approach the format from the manufacturing side.
Rather than treating jelly as a niche product concept, TCI is building specialised expertise around jelly manufacturing, with the goal of giving brands a scalable platform for developing functional nutrition products.
That distinction could become increasingly important as the market moves beyond novelty and into more sophisticated applications.
From consumer experience to nutrient delivery
One of the biggest opportunities – and challenges – in any alternative supplement format is nutrient payload. Consumers may enjoy a product, but ultimately the product needs to deliver an appropriate amount of its intended active ingredients.
That becomes especially important in categories where formulation efficacy depends on delivering meaningful quantities of vitamins, minerals, proteins, botanical compounds or other functional ingredients.
TCI Biotech focuses on this intersection between consumer experience and formulation performance. Its jellie manufacturing capabilities are designed to support higher nutrient payloads while maintaining the sensory qualities that make the format attractive. That opens the door to a broader range of applications.
Instead of limiting jellies to low-dose or purely convenience-oriented products, manufacturers can explore whether the format can support products where nutritional functionality is central to the consumer proposition.
A platform for multiple categories
The potential applications extend across the supplement landscape. Jellies can be considered for categories including vitamins and minerals, healthy ageing, digestive health, immune support, sports and active nutrition, beauty-from-within and other areas of functional wellness.
The format also creates opportunities for brands to think differently about product occasions. A jelly can be designed around portability, a daily wellness ritual, a specific time of day or a particular consumer need. The sensory experience becomes part of the product rather than simply a characteristic of the dosage form.
For brands operating in increasingly crowded categories, that can provide an additional point of differentiation.
And for manufacturers, it creates an opportunity to develop families of products around a common delivery platform, rather than treating every new product as an entirely separate manufacturing challenge.
Manufacturing expertise will shape the category
As interest in jellies grows, manufacturing capability is likely to become one of the key factors determining how quickly the category develops. Producing a consistent, commercially scalable jelly requires more than combining active ingredients with a base.
Formulators must consider texture, flavour, stability, ingredient compatibility, processing conditions, shelf life and the ability to maintain product consistency at scale. Higher nutrient payloads can add another layer of complexity. This is where TCI Biotech believes it can differentiate.
The company’s emphasis on jelly manufacturing reflects a broader CDMO approach that connects formulation development with manufacturing rather than treating the two as separate processes.
That can give brands an opportunity to move from an initial concept to a finished product while addressing the technical requirements of commercial production.
TCI’s broader scientific and R&D infrastructure also provides a foundation for exploring how ingredients and formulations can work within the jelly format. The company describes its approach as integrating research, formulation and manufacturing capabilities to develop products around evolving consumer needs.
Investing in manufacturing infrastructure and formulation capabilities
TCI’s ambitions for the category are becoming increasingly visible. The company is preparing to showcase Jellie™ at SupplySide Global 2026, highlighting five functions and five different textures as examples of how the platform can be customised for different product concepts. That positioning underscores TCI’s view that the opportunity is not simply one jelly product, but a broader delivery platform with multiple functional and sensory possibilities.
That approach puts TCI Biotech in a position to help shape the category as it develops.
The company is not simply responding to interest in jellies at the consumer level. It is investing in the manufacturing infrastructure and formulation capabilities needed to help brands commercialise the format.
That distinction may become increasingly important as demand grows.
The next chapter in functional nutrition
The rise of jellies reflects a fundamental shift in the supplement industry: consumers increasingly want products that deliver nutritional functionality without sacrificing enjoyment or convenience.
For manufacturers, that creates a new set of challenges. The winning products will need to combine compelling consumer experiences with credible formulations, appropriate nutrient levels, stability and scalable production.
That is the opportunity TCI Biotech is pursuing. By making jelly manufacturing a strategic area of focus, TCI is positioning itself not simply as a participant in the emerging jelly trend, but as a company helping define what the format can become.
As the category develops, the question will no longer be whether consumers are interested in jellies. The more important question will be how far manufacturers can push the format – in nutrient payload, functionality, sensory experience and product diversity.
TCI Biotech is betting that the answer is considerably further than the industry has yet explored.
